Literature DB >> 21145529

Midpregnancy levels of angiogenic markers in relation to maternal characteristics.

Renée S Mijal1, Claudia B Holzman, Sarosh Rana, S Ananth Karumanchi, Jianling Wang, Alla Sikorskii.   

Abstract

OBJECTIVE: The purpose of this study was to describe relations among maternal demographic and lifestyle characteristics and midpregnancy levels of angiogenic markers (soluble Fms-like tyrosine kinase-1, placental growth factor, soluble endoglin). STUDY
DESIGN: In a large pregnancy cohort, linear models were used to evaluate relations among maternal characteristics and midpregnancy angiogenic markers with and without covariate adjustment. Associations were examined in a subcohort that included term and preterm deliveries (n = 1302) and among "normal" term pregnancies (n = 668).
RESULTS: Concentrations of all factors declined with increasing maternal body mass index. Multiparous women had lower soluble Fms-like tyrosine kinase-1 levels than primiparous women. Higher placental growth factor and slightly lower soluble endoglin levels were observed among women who smoked at enrollment, but not among those women who quit before enrollment. African American women had higher levels of all markers.
CONCLUSION: Understanding relations among maternal characteristics and levels of angiogenic factors may improve studies that use these markers to examine etiology and/or to predict adverse pregnancy outcome.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145529      PMCID: PMC3079927          DOI: 10.1016/j.ajog.2010.10.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  50 in total

Review 1.  Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review.

Authors:  A Conde-Agudelo; F Althabe; J M Belizán; A C Kafury-Goeta
Journal:  Am J Obstet Gynecol       Date:  1999-10       Impact factor: 8.661

2.  First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Authors:  Ravi Thadhani; Walter P Mutter; Myles Wolf; Richard J Levine; Robert N Taylor; Vikas P Sukhatme; Jeffrey Ecker; S Ananth Karumanchi
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

3.  A multivariate analysis of risk factors for preeclampsia.

Authors:  B Eskenazi; L Fenster; S Sidney
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

4.  The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.

Authors:  D K Waller; L S Lustig; G C Cunningham; L B Feuchtbaum; E B Hook
Journal:  Obstet Gynecol       Date:  1996-11       Impact factor: 7.661

5.  A United States national reference for fetal growth.

Authors:  G R Alexander; J H Himes; R B Kaufman; J Mor; M Kogan
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

6.  Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses.

Authors:  M P Hamilton; H I Abdalla; C R Whitfield
Journal:  Obstet Gynecol       Date:  1985-04       Impact factor: 7.661

7.  Refinements in managing maternal weight adjustment for interpreting prenatal screening results.

Authors:  L M Neveux; G E Palomaki; D A Larrivee; G J Knight; J E Haddow
Journal:  Prenat Diagn       Date:  1996-12       Impact factor: 3.050

8.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 9.  Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders.

Authors:  M Autiero; A Luttun; M Tjwa; P Carmeliet
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

10.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

View more
  16 in total

Review 1.  Epidemiology of preeclampsia: impact of obesity.

Authors:  Arun Jeyabalan
Journal:  Nutr Rev       Date:  2013-10       Impact factor: 7.110

2.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

3.  Maternal angiogenic profile in pregnancies that remain normotensive.

Authors:  Jessica M Faupel-Badger; Anne Cathrine Staff; Ravi Thadhani; Camille E Powe; Nancy Potischman; Robert N Hoover; Rebecca Troisi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-10       Impact factor: 2.435

Review 4.  A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.

Authors:  Sayuri Padayachee; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2019-07-24       Impact factor: 5.369

5.  Lead exposure and association with angiogenic factors and hypertensive disorders of pregnancy.

Authors:  Katherine M Johnson; Aaron J Specht; Jessica M Hart; Saira Salahuddin; Adrienne L Erlinger; Michele R Hacker; Alan D Woolf; Marissa Hauptman; S Ananth Karumanchi; Blair J Wylie; Karen O'Brien
Journal:  Pregnancy Hypertens       Date:  2020-07-31       Impact factor: 2.899

6.  Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.

Authors:  Juan Yang; Michelle Pearl; Gerald N DeLorenze; Roberto Romero; Zhong Dong; Laura Jelliffe-Pawlowski; Robert Currier; Monica Flessel; Martin Kharrazi
Journal:  Am J Obstet Gynecol       Date:  2016-04-09       Impact factor: 8.661

7.  Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery.

Authors:  Renée S Mijal; Claudia B Holzman; Sarosh Rana; S Ananth Karumanchi; Jianling Wang; Alla Sikorskii
Journal:  J Matern Fetal Neonatal Med       Date:  2011-10-24

Review 8.  New developments in the pathogenesis of preeclampsia.

Authors:  Mihran V Naljayan; S Ananth Karumanchi
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

9.  Early Prognostic Factors for the Progress of Preeclampsia - Our Experience in the Period 2010-2011.

Authors:  Mariya Angelova; Ivan Todorov; Emil Kovachev
Journal:  Open Access Maced J Med Sci       Date:  2016-08-06

10.  Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy.

Authors:  Deepali Sundrani; Vinita Khot; Hemlata Pisal; Savita Mehendale; Girija Wagh; Asmita Joshi; Sadhana Joshi
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.